

| Numéro de catalogue | HV357022 |
|---|---|
| Description |
Recombinant Human MAVS Protein, N-His (HV357022) expressed in E. coli, spanning Pro2-Pro97. Purity: >90% by SDS-PAGE.
Highlights
|
| Système d'expression | E. coli |
| Numéro d'accès | Q7Z434 |
| Longueur de protéine | Pro2-Pro97 |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Espèces | Homo sapiens (Human) |
| Nature | Recombinant |
| Niveau d'endotoxines | Please contact with the lab for this information. |
| Pureté | >90% as determined by SDS-PAGE. |
| Masse moléculaire prédite | 13.48 kDa |
| Forme | Lyophilized |
| Tampon de stockage | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot. |
| Reconstitution | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| Expédition | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Stabilité et stockage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Noms alternatifs | CARD adapter inducing interferon beta, Cardif, IPS-1, IPS1, Interferon beta promoter stimulator protein 1, KIAA1271, MAVS, Mitochondrial antiviral-signaling protein, Putative NF-kappa-B-activating protein 031N, VISA, Virus-induced-signaling adapter |
| Contexte | Mitochondrial antiviral-signaling protein is a ~56 kDa protein. Adapter required for innate immune defense against viruses. Acts downstream of DHX33, RIGI and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFNB and RANTES (CCL5). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. May activate the same pathways following detection of extracellular dsRNA by TLR3. 1. Seth, RB. et al. (2005) Cell 122, 669-82. PMID: 16125763 2. Kawai, T. et al. (2005) Nature immunology 6, 981-8. PMID: 16127453 3. Xu, LG. et al. (2005) Molecular cell 19, 727-40. PMID: 16153868 4. Meylan, E. et al. (2005) Nature 437, 1167-72. PMID: 16177806 5. Chiu, YH. et al. (2009) Cell 138, 576-91. PMID: 19631370 6. Oshiumi, H. et al. (2010) European journal of immunology 40, 940-8. PMID: 20127681 7. Dixit, E. et al. (2010) Cell 141, 668-81. PMID: 20451243 8. Oshiumi, H. et al. (2010) PloS one 5, e14258. PMID: 21170385 9. Wang, Y. et al. (2012) Journal of immunology (Baltimore, Md. : 1950) 189, 5304-13. PMID: 23087404 10. Liu, B. et al. (2017) Nature immunology 18, 214-224. PMID: 27992402 |
| Note | For research use only |
Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]
+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский